Aberrations in folate metabolic pathway and altered susceptibility to autism
暂无分享,去创建一个
Usha Naik | R. Akella | Ram Singh | Naushad Shaik Mohammad | Jamal Md Nurul Jain | Krishna Prasad Chintakindi | Ram Prakash Singh | Radha Rama Devi Akella | U. Naik | Jamal Mohammed Nurul Jain | Ram Singh | Radha Akella
[1] P. Kidd. Autism, an extreme challenge to integrative medicine. Part: 1: The knowledge base. , 2002, Alternative medicine review : a journal of clinical therapeutic.
[2] S. Folstein,et al. Etiology of autism: genetic influences. , 1991, Pediatrics.
[3] J. Galanko,et al. Association of MTHFR Gene Variants with Autism , 2004 .
[4] E. Callaway,et al. Clinical and biological effects of high doses of vitamin B6 and magnesium on autistic children. , 1982, Acta vitaminologica et enzymologica.
[5] H. Blom,et al. Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects? , 2001, Molecular genetics and metabolism.
[6] Katherine L. Herbig,et al. Cytoplasmic Serine Hydroxymethyltransferase Mediates Competition between Folate-dependent Deoxyribonucleotide andS-Adenosylmethionine Biosyntheses* , 2002, The Journal of Biological Chemistry.
[7] R. Matthews,et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.
[8] Zhoutao Chen,et al. Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[9] B. Rimland. Controversies in the Treatment of Autistic Children: Vitamin and Drug Therapy , 1988, Journal of child neurology.
[10] R. Finnell,et al. Cerebral folate deficiency with developmental delay, autism, and response to folinic acid , 2005, Neurology.
[11] A. Neugut,et al. Polymorphisms of one-carbon-metabolizing genes and risk of breast cancer in a population-based study. , 2007, Carcinogenesis.
[12] David W Gaylor,et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. , 2004, The American journal of clinical nutrition.
[13] A. Aro,et al. Polymorphisms of key enzymes in homocysteine metabolism affect diet responsiveness of plasma homocysteine in healthy women. , 2001, The Journal of nutrition.
[14] G. Morgan,et al. Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. , 2002, Blood.
[15] J. Akinsanya. The knowledge base. , 1981, Nursing times.
[16] S. Naushad,et al. Relationship between methionine synthase, methionine synthase reductase genetic polymorphisms and deep vein thrombosis among South Indians , 2008, Clinical chemistry and laboratory medicine.
[17] David A Geier,et al. A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism. , 2004, Medical science monitor : international medical journal of experimental and clinical research.
[18] A. Bailey,et al. Autism as a strongly genetic disorder: evidence from a British twin study , 1995, Psychological Medicine.
[19] G. Shaw,et al. Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects. , 2003, Molecular genetics and metabolism.
[20] J. Mason,et al. Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal , 2004, Molecular Psychiatry.
[21] A. Evans,et al. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. , 2001, Atherosclerosis.
[22] R. Rozen,et al. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. , 1999, Molecular genetics and metabolism.
[23] T. Wilens,et al. Decreased Transmethylation of Biogenic Amines After In Vivo Elevation of Brain S‐Adenosyl‐l‐Homocysteine , 1981, Journal of neurochemistry.
[24] R. Matthews,et al. Human methionine synthase reductase is a molecular chaperone for human methionine synthase. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[25] S. Naushad,et al. Prevalence of methylene tetrahydrofolate reductase polymorphism in South Indian population , 2004 .
[26] F. Gabreëls,et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? , 1998, American journal of human genetics.
[27] S. Masetti,et al. Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage , 2003, European Journal of Human Genetics.
[28] J. Bressler,et al. A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A , 2004, American journal of medical genetics. Part A.
[29] Stepan Melnyk,et al. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[30] P. Chiang. Biological effects of inhibitors of S-adenosylhomocysteine hydrolase. , 1998, Pharmacology & therapeutics.
[31] J. Clegg,et al. Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. , 1998, American journal of human genetics.
[32] I. Pogribny,et al. Increase in Plasma Homocysteine Associated with Parallel Increases in Plasma S-Adenosylhomocysteine and Lymphocyte DNA Hypomethylation* , 2000, The Journal of Biological Chemistry.
[33] P. Stover,et al. 5-Formyltetrahydrofolate Regulates Homocysteine Remethylation in Human Neuroblastoma* , 1997, The Journal of Biological Chemistry.
[34] A. Brice,et al. Combined vitamin B6-magnesium treatment in autism spectrum disorder. , 2002, The Cochrane database of systematic reviews.